Alpha Cognition (ACOG) vs Retension Pharmaceuticals (RTSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
Alpha Cognition is the larger company by market cap ($192.5 million vs $89.2 million), about 2.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ACOG | RTSN |
|---|---|---|
| Share price | $8.84 | $11.32 |
| Market cap | $192.52M | $89.22M |
| 1-day change | -2.21% | +7.50% |
| YTD return | +39.08% | — |
| 1-year return | +28.32% | — |
| EPS (TTM) | $-1.32 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.14 | $11.79 |
| 52-week low | $4.50 | $9.66 |
| Distance from 52-week high | -12.82% | -3.99% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +103.62% | — |
| Average volume | 125.15K | 789.20K |
| Shares outstanding | 21.78M | 7.88M |
| Employees | 71 | 12 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alpha Cognition is about 2.2 times larger than Retension Pharmaceuticals by market value ($192.52M vs $89.22M).
- The two companies sit in different sectors: Alpha Cognition in Healthcare and Retension Pharmaceuticals in Health Care.
About Alpha Cognition
ACOG stock →Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Healthcare · Biotechnology · 71 employees
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
ACOG vs RTSN FAQ
Which is bigger, Alpha Cognition or Retension Pharmaceuticals?
Alpha Cognition (ACOG) is larger, with a market capitalization of $192.52M compared with $89.22M for Retension Pharmaceuticals (RTSN).
Are Alpha Cognition and Retension Pharmaceuticals in the same industry?
No. Alpha Cognition is in the Healthcare sector, while Retension Pharmaceuticals is in Health Care.